Table 3.

Table showing localisation of metastasis, pathologic and treatment characteristics and outcome of patients with metastatic disease at presentation.

Localisation of metastasis	Histology (Mixed or pure SmCC)	Treatment	Response	Survival (months)	Death
Liver and Lung and Mediastinum	Mixed	CT (22EP)	PR > 70%	51.8	no
Lung and bone	Pure	CT (4EP) + RT (Y 45 Gy) + RT in the bladder (24 Gy).	PR < 50%	11.7	yes
Bone	Pure	none	NA	1	yes

SmCC = small cell carcinoma; CNS = central nervous system; RP = retroperitoneal; EP = etoposide and cisplatin; G = gemcitabine; GC = gemcitabine plus cisplatin; MVAC = methotrexate, vinblastine, doxorubicin and cisplatin; MTX = methotrexate; CT = chemotherapy; RT = radiotherapy; Y = Y field radiotherapy; PR = partial response; NA = not applicable